Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis.

Lu, Xiaoyan; Jarrett, James; Sadler, Susannah; Tan, Min; Dennis, James; Jairath, Vipul

Lu, Xiaoyan; Jarrett, James; Sadler, Susannah; Tan, Min; Dennis, James; Jairath, Vipul.

Afiliação

Lu X; Value and Market Access, Galapagos NV, Romainville, France.
Jarrett J; HEOR Global Value and Access, Gilead Sciences Inc, Foster City, CA, USA.
Sadler S; Health Economics and Outcomes Research Ltd, Cardiff, UK.
Tan M; Health Economics and Outcomes Research Ltd, Cardiff, UK.
Dennis J; Value Communication, Health Economics and Outcomes Research Ltd, Cardiff, UK.
Jairath V; Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada. vjairath@uwo.ca.

Int J Clin Pharm ; 45(2): 330-341, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36484968

Assuntos

Produtos Biológicos; Colite Ulcerativa; Humanos; Colite Ulcerativa/diagnóstico; Colite Ulcerativa/tratamento farmacológico; Infliximab/uso terapêutico; Adalimumab/uso terapêutico; Metanálise em Rede; Teorema de Bayes

Palavras-chave

Comparative efficacy; Inflammatory bowel disease; Meta-analysis; Ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Colite Ulcerativa Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Int J Clin Pharm Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google